- Home
- UCTT vs DYN Comparison
UCTT vs DYN Comparison
Compare UCTT & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UCTT
- DYN
- Stock Information
- Founded
- UCTT 1991
- DYN 1984
- Country
- UCTT United States
- DYN United States
- Employees
- UCTT N/A
- DYN N/A
- Industry
- UCTT Semiconductors
- DYN Medicinal Chemicals and Botanical Products
- Sector
- UCTT Technology
- DYN Health Care
- Exchange
- UCTT Nasdaq
- DYN Nasdaq
- Market Cap
- UCTT 1.1B
- DYN 1.2B
- IPO Year
- UCTT 2004
- DYN 2020
- Fundamental
- Price
- UCTT $23.95
- DYN $9.57
- Analyst Decision
- UCTT Strong Buy
- DYN Strong Buy
- Analyst Count
- UCTT 4
- DYN 15
- Target Price
- UCTT $43.25
- DYN $43.07
- AVG Volume (30 Days)
- UCTT 518.8K
- DYN 3.3M
- Earning Date
- UCTT 07-28-2025
- DYN 08-11-2025
- Dividend Yield
- UCTT N/A
- DYN N/A
- EPS Growth
- UCTT N/A
- DYN N/A
- EPS
- UCTT 0.62
- DYN N/A
- Revenue
- UCTT $2,138,500,000.00
- DYN N/A
- Revenue This Year
- UCTT N/A
- DYN N/A
- Revenue Next Year
- UCTT $1.85
- DYN N/A
- P/E Ratio
- UCTT $38.96
- DYN N/A
- Revenue Growth
- UCTT 20.21
- DYN N/A
- 52 Week Low
- UCTT $16.66
- DYN $6.36
- 52 Week High
- UCTT $54.00
- DYN $47.45
- Technical
- Relative Strength Index (RSI)
- UCTT 56.40
- DYN 44.52
- Support Level
- UCTT $24.88
- DYN $8.95
- Resistance Level
- UCTT $26.32
- DYN $9.83
- Average True Range (ATR)
- UCTT 0.97
- DYN 0.54
- MACD
- UCTT -0.07
- DYN 0.15
- Stochastic Oscillator
- UCTT 30.83
- DYN 67.80
About UCTT Ultra Clean Holdings Inc.
Ultra Clean Holdings Inc, through its subsidiaries, manufactures and supplies production tools, modules, and subsystems for the semiconductor capital equipment industry. The product includes precision robotic solutions, gas delivery systems, and a variety of industrial and automation production equipment products; subsystems include wafer cleaning subsystems, chemical delivery modules, top-plate assemblies, frame assemblies, and process modules. Its customer base includes firms in the semiconductor capital equipment industry, medical, energy, industrial, flat panel, and research equipment industries. It has two segments Products and Services. Its principal markets are Americas, Asia Pacific and EMEA.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.